{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:54:34Z","timestamp":1777035274653,"version":"3.51.4"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s11239-006-6579-0","type":"journal-article","created":{"date-parts":[[2006,5,8]],"date-time":"2006-05-08T13:20:48Z","timestamp":1147094448000},"page":"221-227","source":"Crossref","is-referenced-by-count":19,"title":["Enhanced spontaneous thrombolysis: A new therapeutic challenge"],"prefix":"10.1007","volume":"21","author":[{"given":"I. B.","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Gorog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6579_CR1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0735-1097(89)90325-2","volume":"13","author":"HJ Swan","year":"1989","unstructured":"Swan HJ (1989) Acute myocardial infarction: a failure of timely, spontaneous thrombolysis. J Am Coll Cardiol 13:1435\u20131437","journal-title":"J Am Coll Cardiol"},{"key":"6579_CR2","first-page":"271","volume":"46","author":"B Osterlund","year":"2002","unstructured":"Osterlund B, Andersson B, Haggmark S et al. (2002) Myocardial ischemia induces coronary t-PA release in the pig. Acta Anaesthesiol. Scand 46:271\u2013278","journal-title":"Scand"},{"key":"6579_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.STR.31.1.26","volume":"31","author":"L Johansson","year":"2000","unstructured":"Johansson L, Jansson JH, Boman K (2000) Tissue plasminogen activator, plasminogen activator inhibitor and tissue plasminogen activator\/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke 31:26\u201332","journal-title":"Stroke"},{"key":"6579_CR4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM198010163031601","volume":"303","author":"MA DeWood","year":"1980","unstructured":"DeWood MA, Spores J, Notske R (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303:897\u2013902","journal-title":"N Engl J Med"},{"key":"6579_CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1378\/chest.84.3.302","volume":"84","author":"TA Sanborn","year":"1983","unstructured":"Sanborn TA, Faxon DP, Kellett MA (1983) Serial angiographic evidence of rapid resolution of coronary artery stenosis. Chest 84:302\u2013304","journal-title":"Chest"},{"key":"6579_CR6","first-page":"24","volume":"28","author":"LS Zingerman","year":"1988","unstructured":"Zingerman LS, Golikov AP, Topchiian GS (1988) The possibility of spontaneous lysis of a coronary thrombus patient, with acute myocardial infarct. Kardioologiia 28:24\u201328","journal-title":"Kardioologiia"},{"key":"6579_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-8703(98)70317-5","volume":"135","author":"TF Christian","year":"1998","unstructured":"Christian TF, Milavetz, JJ, Miller TD (1998) Prevalence of spontaneous reperfusion and associated myocardial salvage in patients with acute myocardial infarction. Am Heart J 135:421\u2013427","journal-title":"Am Heart J"},{"key":"6579_CR8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0002-9149(01)01427-8","volume":"87","author":"CW Lee","year":"2001","unstructured":"Lee CW, Hong MK, Lee JH (2001) Determinants and prognostic significance of spontaneous coronary recanalization in acute myocardial infarction. Am J Cardiol 87:951\u2013953","journal-title":"Am J Cardiol"},{"key":"6579_CR9","first-page":"271","volume":"347","author":"CE Seibert","year":"1976","unstructured":"Seibert CE, Swanson WB (1976) Lysis of thrombus in internal carotid artery in the neck. Report of a case. Acta Radiol Suppl, 347:271\u2013275","journal-title":"Acta Radiol Suppl"},{"key":"6579_CR10","first-page":"245","volume":"83","author":"HJ Engel","year":"1977","unstructured":"Engel HJ, Lichtlen P (1977) Indications for a spontaneous lysis in the human coronary system\u2013-coronary stenosis as a dynamic process? Verh Dtsch Ges Inn. Med 83:245\u2013249","journal-title":"Med"},{"key":"6579_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02552672","volume":"7","author":"MA Weiner","year":"1984","unstructured":"Weiner MA, Sniderman KW, Sos TA (1984) Two cases of spontaneous lysis of arterial thrombi. Cardiovasc Intervent Radiol 7:24\u201327","journal-title":"Cardiovasc Intervent Radiol"},{"key":"6579_CR12","first-page":"172","volume":"42","author":"W Weber","year":"1989","unstructured":"Weber W, Hotker U, Schild H (1989) Spontaneous arterial recanalization\u2013-a case report. Rontgenblatter 42:172\u2013173","journal-title":"Rontgenblatter"},{"key":"6579_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2007-1006450","volume":"12","author":"LE Chen","year":"1996","unstructured":"Chen LE, Seaber AV, Urbaniak JR (1996) Thrombosis and thrombolysis in crushed arteries with or without anastomosis: a new microvascular model. Reconstr Microsurg 12:31\u201338.","journal-title":"Reconstr Microsurg"},{"key":"6579_CR14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1246-7820(00)88980-6","volume":"6","author":"VB Schini\u2013Kerth","year":"1999","unstructured":"Schini\u2013Kerth VB (1999) Vascular biosynthesis of nitric oxide: effect on hemostasis and fibrinolysis. Transfus Clin Biol 6:355\u2013363","journal-title":"Transfus Clin Biol"},{"key":"6579_CR15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.LAB.0000073127.46392.9D","volume":"83","author":"R Rosenhek","year":"2003","unstructured":"Rosenhek R, Korschineck I, Gharehbaghi\u2013Schnell E (2003) Fibrinolytic balance of the arterial wall: pulmonary artery displays increased fibrinolytic potential compared with aorta. Lab Invest 83:871\u2013876","journal-title":"Lab Invest"},{"key":"6579_CR16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1055\/s-0037-1613306","volume":"88","author":"B Zeng","year":"2002","unstructured":"Zeng B, Bruce D, Kril J (2002) Influence of plasminogen deficiency on the contribution of polymorphonuclear leucocytes to fibrin\/ogenolysis: studies in plasminogen knock\u2013out mice. Thromb Haemost 88:805\u2013810","journal-title":"Thromb Haemost"},{"key":"6579_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0967-2109(97)00162-2","volume":"6","author":"KG Burnand","year":"1998","unstructured":"Burnand KG, Gaffney PJ, McGuinness CL (1998) The role of the monocyte in the generation and dissolution of arterial and venous thrombi. Cardiovasc Surg 6:119\u2013125","journal-title":"Cardiovasc Surg"},{"key":"6579_CR18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.79.4.920","volume":"79","author":"IK Jang","year":"1989","unstructured":"Jang IK, Gold HK, Ziskind AA (1989) Differential sensitivity of erythrocyte\u2013rich and platelet\u2013rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. Circulation 79:920\u2013928","journal-title":"Circulation"},{"key":"6579_CR19","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.STR.0000080941.73934.30","volume":"34","author":"F Niessen","year":"2003","unstructured":"Niessen F, Hilger T, Hoehn M et al. (2003) Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke 34:2019\u20132024","journal-title":"Stroke"},{"key":"6579_CR20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0049-3848(93)90241-F","volume":"72","author":"SR Torr-Brown","year":"1993","unstructured":"Torr-Brown SR, Sobel BE (1993) Attenuation of thrombolysis by release of plasminogen activator inhibitor type\u20131 from platelets. Thromb Res 72:413\u2013421","journal-title":"Thromb Res"},{"key":"6579_CR21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0038-1650232","volume":"75","author":"LA Robbie","year":"1996","unstructured":"Robbie LA, Bennett B, Croll AM (1996) Proteins of the fibrinolytic system in human thrombi. Thromb Haemost 75:127\u2013133","journal-title":"Thromb Haemost"},{"key":"6579_CR22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1161\/01.ATV.16.10.1277","volume":"16","author":"WP Fay","year":"1996","unstructured":"Fay WP, Murphy JG, Owen WG (1996) High concentrations of active plasminogen activator inhibitor in porcine coronary artery thrombi. Arterioscler. Thromb Vasc Biol 16:1277\u20131284","journal-title":"Thromb Vasc Biol"},{"key":"6579_CR23","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1182\/blood-2002-09-2944","volume":"101","author":"LO Mosnier","year":"2003","unstructured":"Mosnier LO, Buijtenhuijs P, Marx PF (2003) Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 101:4844\u20134846","journal-title":"Blood"},{"key":"6579_CR24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-2141.2001.02696.x","volume":"113","author":"E Moir","year":"2001","unstructured":"Moir E, Booth NA, Bennett B, Roppic LA. (2001) Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism. Br J Haematol 113:72\u201380","journal-title":"Br J Haematol"},{"key":"6579_CR25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0049-3848(85)90193-8","volume":"37","author":"FB Taylor Jr.","year":"1985","unstructured":"Taylor FB Jr, Lockhart MS (1985) Whole blood clot lysis: In vitro modulation by activated protein C. Thromb Res 37:639\u2013649","journal-title":"Thromb Res"},{"key":"6579_CR26","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1016\/S0021-9258(18)89179-7","volume":"260","author":"TC Wun","year":"1985","unstructured":"Wun TC, Capuano A (1985) Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. J Biol Chem 260:5061\u20135066","journal-title":"J Biol Chem"},{"key":"6579_CR27","first-page":"329","volume":"23","author":"A Glassman","year":"1993","unstructured":"Glassman A, Abram M, Baxter G, Swett A (1993) Euglobulin lysis times: an update. Ann Clin Lab Sci 23:329\u2013332","journal-title":"Ann Clin Lab Sci"},{"key":"6579_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6750-2-8","volume":"2","author":"KZ Boudjeltia","year":"2002","unstructured":"Boudjeltia KZ, Cauchie P, Remacle CM (2002) A new device for measurement of fibrin clot lysis: application for the Euglobulin Clot Lysis Time. BMC. Biotechnol 2:8.","journal-title":"BMC Biotechnol"},{"key":"6579_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0167-5273(02)00186-9","volume":"85","author":"T Soeki","year":"2002","unstructured":"Soeki T, Tamura Y, Shinohara H (2002) Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death. Int J Cardiol 85:277\u2013283","journal-title":"Int J Cardiol"},{"key":"6579_CR30","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/01.CIR.88.5.2030","volume":"88","author":"JH Jansson","year":"1993","unstructured":"Jansson JH, Olofsson BO, Nilsson TK (1993) Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. Circulation 88:2030\u20132034","journal-title":"Circulation"},{"key":"6579_CR31","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/01.ATV.18.10.1634","volume":"18","author":"A Geppert","year":"1998","unstructured":"Geppert A, Graf S, Beckmann R (1998) Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. Arterioscler Thromb Vasc Biol 18:1634\u20131642","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6579_CR32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1179\/acb.2002.060","volume":"57","author":"K Ver Elst","year":"2002","unstructured":"Ver Elst K, Jochmans K, De Pauw A, et al. (2002) Plasma D-dimer concentrations in different clinical conditions. Acta Clin Belg 57:325\u2013330","journal-title":"Acta Clin Belg"},{"key":"6579_CR33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1055\/s-0038-1653877","volume":"73","author":"OD Pedersen","year":"1995","unstructured":"Pedersen OD, Gram J, Jespersen J (1995) Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease. Thromb Haemost 73:835\u2013 840","journal-title":"Thromb Haemost"},{"key":"6579_CR34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0889-8588(02)00086-2","volume":"17","author":"HC Kwaan","year":"2003","unstructured":"Kwaan HC, Nabhan C (2003) Hereditary and acquired defects in the fibrinolytic system associated with thrombosis. Hematol Oncol Clin North Am 17:103\u2013114","journal-title":"Hematol Oncol Clin North Am"},{"key":"6579_CR35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/01.ATV.0000015445.22243.F4","volume":"22","author":"I Juhan-Vague","year":"2002","unstructured":"Juhan-Vague I, Morange PE, Aubert H (2002) Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol 22:867\u2013873","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6579_CR36","first-page":"D239","volume":"6","author":"HR Lijnen","year":"2001","unstructured":"Lijnen HR (2001) Gene targeting in hemostasis. Alpha2-antiplasmin. Front Biosci 6 :D239\u201347","journal-title":"Front Biosci"},{"key":"6579_CR37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1055\/s-0037-1615105","volume":"79","author":"M Stegnar","year":"1998","unstructured":"Stegnar M, Uhrin P, Peternel P (1998) The 4G\/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 gene: relationship to plasma PAI-1 levels in venous thromboembolism. Thromb Haemost 79:975\u2013979","journal-title":"Thromb Haemost"},{"key":"6579_CR38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1373\/49.7.1081","volume":"49","author":"A Dossenbach\u2013Glaninger","year":"2003","unstructured":"Dossenbach\u2013Glaninger A, van Trotsenburg M, Dossenbach M (2003) Plasminogen activator inhibitor-1 4G\/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 49:1081\u2013 1086","journal-title":"Clin Chem"},{"key":"6579_CR39","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1161\/01.STR.0000098004.26252.EB","volume":"34","author":"T Hoekstra","year":"2003","unstructured":"Hoekstra T, Geleijnse JM, Kluft C (2003) 4G\/4G Genotype of PAI-1 is associated with reduced risk of stroke in elderly. Stroke 34:2822\u20132828","journal-title":"Stroke"},{"key":"6579_CR40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(70)90747-6","volume":"1","author":"IS Menon","year":"1970","unstructured":"Menon IS (1970) Aspirin and blood fibrinolysis. Lancet 1:364.","journal-title":"Lancet"},{"key":"6579_CR41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM197703102961001","volume":"296","author":"LA Moroz","year":"1977","unstructured":"Moroz LA (1977) Increased blood fibrinolytic activity after aspirin ingestion. N Engl J Med 296:525\u2013529","journal-title":"N Engl J Med"},{"key":"6579_CR42","first-page":"154","volume":"250","author":"TD Bjornsson","year":"1989","unstructured":"Bjornsson TD, Schneider DE, Berger H Jr (1989) Aspirin acetylates fibrinogen and enhances fibrinolysis. J Pharmacol Exp Ther 250:154\u2013161","journal-title":"J Pharmacol Exp Ther"},{"key":"6579_CR43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0038-1648158","volume":"65","author":"A Milwidsky","year":"1991","unstructured":"Milwidsky A, Finci\u2013Yeheskel Z, Mayer M (1991) Stimulation of plasmin by aspirin. Thromb Haemostas 65:389\u2013393","journal-title":"Thromb Haemostas"},{"key":"6579_CR44","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood.V74.5.1635.1635","volume":"74","author":"RI Levin","year":"1989","unstructured":"Levin RI, Harpel PC, Harpel JG, et al. (1989) Inhibition of tissue plasminogen activator activity by aspirin in vivo. Blood 74:1635\u20131643","journal-title":"Blood"},{"key":"6579_CR45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0049-3848(87)90282-9","volume":"46","author":"I Keber","year":"1987","unstructured":"Keber I, Jereb M, Keber D (1987) Aspirin decreases fibrinolytic potential during venous occlusion but not during acute physical activity. Thromb Res 46:205\u2013212","journal-title":"Thromb Res"},{"key":"6579_CR46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI111454","volume":"74","author":"RI Levin","year":"1984","unstructured":"Levin RI, Harpel PC, Weil D, et al. (1984) Aspirin inhibits plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity. J Clin Invest 74:571\u2013580","journal-title":"J Clin Invest"},{"key":"6579_CR47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0002-9149(94)90939-3","volume":"73","author":"K Winther","year":"1994","unstructured":"Winther K, Gleerup G, Husted S (1994) Do low and moderate doses of acetylsalicylic acid affect tissue plasminogen activator at rest and after exercise? Am J Cardiol 73:703\u2013705","journal-title":"Am J Cardiol"},{"key":"6579_CR48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1055\/s-0038-1656353","volume":"68","author":"SE Husted","year":"1992","unstructured":"Husted SE, Kristensen SD, Vissinger H, et al. (1992) Intravenous acetylsalicylic acid\u2013dose related effects on platelet function and fibrinolysis in healthy males. Thromb Haemost 68:226\u2013229","journal-title":"Thromb Haemost"},{"key":"6579_CR49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","volume":"88","author":"PA Gum","year":"2001","unstructured":"Gum PA, Kottke-Marchant K, Poggio ED (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88:230\u2013235","journal-title":"Am J Cardiol"},{"key":"6579_CR50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(96)00256-7","volume":"308","author":"RJ Gryglewski","year":"1996","unstructured":"Gryglewski RJ, Korbut R, Swies J, et al. (1996) Thrombolytic action of ticlopidine: Possible mechanisms. Eur J Pharmacol 308:61\u2013 67","journal-title":"Eur J Pharmacol"},{"key":"6579_CR51","first-page":"4","volume":"43","author":"NN Slavina","year":"2003","unstructured":"Slavina NN, Averkov OV, Dobrovolskii AB, et al. (2003) Non ST elevation acute coronary syndrome. Parameters of fibrinolysis during short term use of ticlopidine or clopidogrel. Kardiologiia 43:4\u201311","journal-title":"Kardiologiia"},{"key":"6579_CR52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2004.05.004","volume":"114","author":"TH Taher","year":"2004","unstructured":"Taher TH, Stang L, Gordon PA, et al. (2004) Armstrong PW. Clopidogrel does not induce fibrinolysis in healthy subjects. Thromb Res 114:97\u2013100","journal-title":"Thromb Res"},{"key":"6579_CR53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00005344-200304000-00011","volume":"41","author":"M Moser","year":"2003","unstructured":"Moser M, Bertram U, Peter K, et al. (2003) Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. J Cardiovasc Pharmacol 41:586\u2013592","journal-title":"J Cardiovasc Pharmacol"},{"key":"6579_CR54","doi-asserted-by":"crossref","first-page":"d1085","DOI":"10.2741\/1140","volume":"8","author":"BE Sobel","year":"2003","unstructured":"Sobel BE (2003) Fibrinolysis and diabetes. Front Biosci 8:d1085\u201392","journal-title":"Front Biosci"},{"key":"6579_CR55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11883-002-0037-z","volume":"4","author":"E Chiquette","year":"2002","unstructured":"Chiquette E, Chilton R (2002) Cardiovascular disease: much more aggressivein patients with type 2 diabetes. Curr Atheroscler Rep 4:134\u2013142","journal-title":"Curr Atheroscler Rep"},{"key":"6579_CR56","doi-asserted-by":"crossref","first-page":"6S117","DOI":"10.1016\/S1262-3636(03)72796-7","volume":"29","author":"P Libby","year":"2003","unstructured":"Libby P (2003) Metformin and vascular protection: a cardiologist\u2019s view. Diabetes Metab 29:6S117\u2013120","journal-title":"Diabetes Metab"},{"key":"6579_CR57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11883-005-0075-4","volume":"7","author":"B Panunti","year":"2005","unstructured":"Panunti B, Kunhiraman B, Fonseca V (2005) The impact of antidiabetic therapies on cardiovascular diseases. Curr Atheroscler Rep 7:50\u201357","journal-title":"Curr Atheroscler Rep"},{"key":"6579_CR58","first-page":"G9","volume":"G","author":"D.E Vaughan","year":"1998","unstructured":"Vaughan, D.E (1998) Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease. Eur Heart J 19, Suppl G:G9\u201312","journal-title":"Eur Heart J 19, Suppl"},{"key":"6579_CR59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.diabres.2005.03.025","volume":"70","author":"S Ludwig","year":"2005","unstructured":"Ludwig S, Dharmalingam S, Erickson-Nesmith S, et al. (2005) Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus. Diabetes Res Clin Pract 70: 110\u2013118","journal-title":"Diabetes Res Clin Pract"},{"key":"6579_CR60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/089686080302300308","volume":"23","author":"JS Malyszko","year":"2003","unstructured":"Malyszko JS, Hryszko T, Mysliwiec M (2003) Influence of simvastatin on aspects of thrombogenesis in CAPD patients. Perit Dial Int 23:260\u2013266","journal-title":"Perit Dial Int"},{"key":"6579_CR61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ahj.2004.06.027","volume":"149","author":"S John","year":"2005","unstructured":"John S, Schneider MP, Delles C, et al. (2005) Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am Heart J 149:473\u2013485","journal-title":"Am Heart J"},{"key":"6579_CR62","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1160\/TH04-02-0064","volume":"91","author":"A Undas","year":"2004","unstructured":"Undas A, Celinska\u2013Lowenhoff M, Kaczor M, et al. (2004) New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost 91:1065\u20131077","journal-title":"Thromb Haemost"},{"key":"6579_CR63","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2165\/00003495-200363170-00005","volume":"63","author":"R Krysiak","year":"2003","unstructured":"Krysiak R, Okopien B, Herman Z (2003) Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolytic processes. Drugs 63:1821\u20131854","journal-title":"Drugs"},{"issue":"4","key":"6579_CR64","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.0000153810.81187.7D","volume":"111","author":"V Sanguigni","year":"2005","unstructured":"Sanguigni V, Pignatelli P, Lenti L, et al. (2005) Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. Circ 111(4):412\u2013419","journal-title":"Circ"},{"key":"6579_CR65","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.RES.0000170229.49776.81","volume":"96","author":"M Yamakuchi","year":"2005","unstructured":"Yamakuchi M, Greer JJ, Cameron SJ, et al. (2005) HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size. Circ Res 96:1185\u20131192","journal-title":"Circ Res"},{"key":"6579_CR66","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/01.ATV.0000183718.62409.ea","volume":"25","author":"U Singh","year":"2005","unstructured":"Singh U, Devaraj S, Jialal I (2005) C\u2013reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C\u2013reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 25:2216\u20132221","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5A","key":"6579_CR67","doi-asserted-by":"crossref","first-page":"61F","DOI":"10.1016\/j.amjcard.2005.07.013","volume":"96","author":"SE Nissen","year":"2005","unstructured":"Nissen SE (2005) Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Am J Cardiol 96(5A):61F\u201368F","journal-title":"Am J Cardiol"},{"key":"6579_CR68","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.amjcard.2005.04.030","volume":"96","author":"K Kinjo","year":"2005","unstructured":"Kinjo K, Sato H, Sakata Y, et al. (2005) Osaka Acute Coronary Insufficiency Study (OACIS) Group. Relation of C\u2013reactive protein and one-year survival after acute myocardial infarction with versus without statin therapy. Am J Cardiol 96:617\u2013621","journal-title":"Am J Cardiol"},{"key":"6579_CR69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00001721-200301000-00007","volume":"14","author":"J Yamamoto","year":"2003","unstructured":"Yamamoto, J, Yamashita T, Ikarugi H, et al. (2003) Thrombosis Test: a global in vitro test of platelet function and thrombolysis. Blood Coagul. Fibrinolysis 14:31\u201339","journal-title":"Fibrinolysis"},{"key":"6579_CR70","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00001721-200312000-00001","volume":"14","author":"J Yamamoto","year":"2003","unstructured":"Yamamoto J, Kovacs IB (2003) Shear-induced in vitro haemostasis\/thrombosis tests: the benefit of using native blood. Blood Coagul Fibrinolysis 14:697\u2013702","journal-title":"Blood Coagul Fibrinolysis"},{"key":"6579_CR71","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00001721-200312000-00016","volume":"14","author":"H Ikarugi","year":"2003","unstructured":"Ikarugi H, Yamashita T, Aoki R (2003) Impaired spontaneous thrombolytic activity in elderly and in habitual smokers, as measured by a new global thrombosis test. Blood Coagul. Fibrinolysis 14:781\u2013784","journal-title":"Fibrinolysis"},{"key":"6579_CR72","unstructured":"Yamashita T, Sato A, Ikarugi H. Significantly reduced spontaneous thrombolytic activity in elderly men: a possible explanation for gender differences in risk of acute coronary syndromes (Thromb. Res., in press)."},{"key":"6579_CR73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH03-12-0764","volume":"91","author":"A Gils","year":"2004","unstructured":"Gils A, Declerck PJ (2004) The structural basis for the pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of potential PAI-1 inhibitors. Thromb Haemost 91:425\u2013437","journal-title":"Thromb Haemost"},{"key":"6579_CR74","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1055\/s-0038-1656086","volume":"77","author":"JJ Giezen van","year":"1997","unstructured":"van Giezen JJ, Wahlund G, Abrahamsson T. (1997) The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis. Thromb Haemost 77:964\u2013969","journal-title":"Thromb Haemost"},{"key":"6579_CR75","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.CIR.91.4.1175","volume":"91","author":"BJ Biemond","year":"1995","unstructured":"Biemond BJ, Levi M, Coronel R, Janse MJ, ten Cate JW, Pannekoek H. (1995) Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1\u2013neutralizing monoclonal antibody. Circulation 91:1175\u20131181","journal-title":"Circulation"},{"key":"6579_CR76","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1172\/JCI117937","volume":"95","author":"DT Eitzman","year":"1995","unstructured":"Eitzman DT, Fay WP, Lawrence DA, et al. (1995) Peptide\u2013mediated inactivation of recombinant and platelet plasminogen activator inhibitor\u20131 in vitro. J Clin Invest 95:2416\u20132420","journal-title":"J Clin Invest"},{"key":"6579_CR77","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-0038-1650371","volume":"75","author":"PA Charlton","year":"1996","unstructured":"Charlton PA, Faint RW, Bent F, (1996) Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. Thromb Haemost 75:808\u2013815","journal-title":"Thromb Haemost"},{"key":"6579_CR78","first-page":"916","volume":"96","author":"PW Friederich","year":"1997","unstructured":"Friederich PW, Levi M, Biemond BJ, et al. (1997) Novel low-molecular-weight inhibitor of PAI-1 (XR5118) promotes endogenous fibrinolysis and reduces postthrombolysis thrombus growth in rabbits. Circulation 96:916\u2013921","journal-title":"Circulation"},{"key":"6579_CR79","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1172\/JCI116893","volume":"92","author":"P Carmeliet","year":"1993","unstructured":"Carmeliet P, Stassen JM, Schoonjans L, et al. (1993) Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 92:2756\u20132760","journal-title":"J Clin Invest"},{"key":"6579_CR80","doi-asserted-by":"crossref","first-page":"32677","DOI":"10.1074\/jbc.M204010200","volume":"277","author":"T Chavakis","year":"2002","unstructured":"Chavakis T, Pixley RA, Isordia-Salas I, Colman RW, Preissner KT. (2002) A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor\u20131 function. J Biol Chem 277:32677\u201332682","journal-title":"J Biol Chem"},{"key":"6579_CR81","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/jpet.105.084129","volume":"314","author":"JK Hennan","year":"2005","unstructured":"Hennan JK, Elokdah H, Leal M, et al. (2005) Evaluation of PAI\u2013039 1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl(oxo)acetic acid], a novel plasminogen activator inhibitor\u20131 inhibitor, in a canine model of coronary artery thrombosis. J Pharmacol Exp Ther 314:710\u2013716","journal-title":"J Pharmacol Exp Ther"},{"key":"6579_CR82","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1124\/jpet.103.062729","volume":"309","author":"K Suzuki","year":"2004","unstructured":"Suzuki K, Muto Y, Fushihara K, et al. (2004) Enhancement of fibrinolysis by EF6265 [(S)-7-amino-2-[[[(R)-2-methyl-1-(3-phenylpropanoylamino)propyl]hydroxyphosphinoyl] methyl]heptanoic acid], a specific inhibitor of plasma carboxypeptidase Br J Pharmacol Exp Ther 309:607\u2013615","journal-title":"Br J Pharmacol Exp Ther"},{"key":"6579_CR83","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0049-3848(91)90347-Y","volume":"64","author":"CH. Nair","year":"1991","unstructured":"Nair CH., Azhar A, Wilson JD., Dhall DP. (1991) Studies on fibrin network structure in human plasma. Thromb Res 64:477\u2013485","journal-title":"Thromb Res"},{"key":"6579_CR84","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1053\/euhj.1998.1088","volume":"19","author":"F Williams","year":"1998","unstructured":"Williams F, Fatah K, Hjemdahl P, Blomback M. (1998) Better increase in fibrin gel porosity by low dose than intermediate does acetylsalicylic acid. Eur Heart J 19:1666\u20131672","journal-title":"Eur Heart J"},{"key":"6579_CR85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/000331970205300114","volume":"53","author":"A Manganaro","year":"2002","unstructured":"Manganaro A, Ruggeri M, Ando G, Longo M, Vita G. (2002) Endothelial functions in pathophysiology of thrombosis and fibrinollysis: late spontaneous recanalization of an occluded internal carotid artery \u2013 a case report. Angiology 53:99\u2013103","journal-title":"Angiology"},{"key":"6579_CR86","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.thromres.2004.10.001","volume":"115","author":"JA Kim","year":"2005","unstructured":"Kim JA, Tran ND, Zhou W, Fisher M. (2005) Dipyridamole enhances tissue plasminogen activator release by brain capillary endothelial cells. Thromb Res 115:435\u2013438","journal-title":"Thromb Res"},{"key":"6579_CR87","first-page":"e48","volume":"96","author":"Z Lin","year":"2005","unstructured":"Lin Z, Kumar A, SenBanerjee S, Staniszewski P, Parmar K, Vaughan DE, Gimbrone MA Jr, Balasubramanian V, Garcia-Gardena G, Jain MK. (2005) Kruppel\u2013like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 96:e48\u2013 57","journal-title":"Circ Res"},{"key":"6579_CR88","first-page":"895","volume":"88","author":"M Marchetti","year":"2003","unstructured":"Marchetti M, Vignoli A, Bani MR, Balducci D, Barbui T, Falanga A. (2003) All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties. Haematologica 88:895\u2013 905","journal-title":"Haematologica"},{"key":"6579_CR89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jnutbio.2004.07.008","volume":"16","author":"PR Chen","year":"2005","unstructured":"Chen PR, Lee CC, Chang H, Tsai CE. (2005) Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system. J Nutr Biochem 16:59\u201364","journal-title":"J Nutr Biochem"},{"key":"6579_CR90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcb.10602","volume":"90","author":"RA Markle","year":"2003","unstructured":"Markle RA, Han J, Summers BD, et al. (2003) Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. J Cell Biochem 90:23\u201332","journal-title":"J Cell Biochem"},{"key":"6579_CR91","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood.V90.4.1527","volume":"90","author":"P Carmeliet","year":"1997","unstructured":"Carmeliet P, Stassen JM, Van Vlaenderen L, Meidell RS, Collen D, Gerard RD. (1997) Adenovirus-mediated transfer if tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice. Blood 90:1527\u20131534","journal-title":"Blood"},{"key":"6579_CR92","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1160\/TH05-01-0038","volume":"94","author":"B Ozuyaman","year":"2005","unstructured":"Ozuyaman B, Ebner P, Nielsner U, et al. (2005) Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost 94:770\u2013772","journal-title":"Thromb Haemost"},{"key":"6579_CR93","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jacc.2005.04.066","volume":"46","author":"T Thum","year":"2005","unstructured":"Thum T, Tsikas D, Stein S, Schultheiss M, Eigenhaler M, Anker SD, Poole-Wilson PA, Ertl G, Bauersachs J. (2005) Supression of endothelial progenitor cells in human coronary artery disease by endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46:1693\u20131701","journal-title":"J Am Coll Cardiol"},{"key":"6579_CR94","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","volume":"45","author":"GP Fadini","year":"2005","unstructured":"Fadini GP, Miorin M, Facco M, et al. (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45:1449\u2013 1457","journal-title":"J Am Coll Cardiol"},{"key":"6579_CR95","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2004.12.074","volume":"45","author":"C Heiss","year":"2005","unstructured":"Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. (2005) Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 45:1441\u2013 1448","journal-title":"J Am Coll Cardiol"},{"key":"6579_CR96","doi-asserted-by":"crossref","unstructured":"Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. (2005) Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis Nov 7","DOI":"10.1016\/j.atherosclerosis.2005.10.009"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-6579-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-006-6579-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-6579-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T10:40:01Z","timestamp":1683456001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-006-6579-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["6579"],"URL":"https:\/\/doi.org\/10.1007\/s11239-006-6579-0","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}